Manavi Sachdeva
Overview
Explore the profile of Manavi Sachdeva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sachdeva M, Blanc-Durand F, Tan D
Int J Gynecol Cancer
. 2025 Mar;
35(3):101681.
PMID: 40054130
Clear cell ovarian and endometrial carcinomas are rare and aggressive gynecologic malignancies that present unique challenges owing to their underrepresentation in clinical trials and limited prospective data. In this report,...
2.
Tay R, Sachdeva M, Ma H, Kim Y, Kook M, Kim H, et al.
Gastric Cancer
. 2025 Feb;
PMID: 39971854
Background: Within the tumor microenvironment (TME), the association of B lymphocytes (B cells) with prognosis and therapy response in gastric cancer (GC) remains poorly characterized. We investigated the predictive and...
3.
Loh J, Low J, Sachdeva M, Low P, Wong R, Huang Y, et al.
Expert Rev Anticancer Ther
. 2023 Aug;
23(9):913-926.
PMID: 37551698
Introduction: The current standard of care of locally advanced non-small cell lung cancer (LA-NSCLC) is concurrent chemoradiation, followed by consolidation durvalumab. However, there is evidence that the efficacy of chemoradiation...
4.
Sachdeva M, Ngoi N, Lim D, Poon M, Thian Y, Lim Y, et al.
Onco Targets Ther
. 2021 Jul;
14:3921-3928.
PMID: 34234460
Background: The optimal treatment and molecular landscape of recurrent clear cell carcinoma of the vulva (VCCC) are unknown. No reported data exist regarding the efficacy of anti-programmed death 1 (PD-1)...
5.
Haddadin Y, Katarey D, Sachdeva M, Vickers L, Kaur I, Hashim A, et al.
Clin Med (Lond)
. 2020 May;
20(3):308-312.
PMID: 32414721
Objective: 'Sensible on Strength' (SoS), a local public health initiative, is aimed at reducing high-strength beer and cider availability. The objective of this study was to assess its impact on...
6.
Klatte T, Fife K, Welsh S, Sachdeva M, Armitage J, Aho T, et al.
World J Urol
. 2017 Dec;
36(3):417-425.
PMID: 29256020
Purpose: To test the hypothesis that cytoreductive nephrectomy (CN) improves overall survival (OS) of patients with synchronous metastatic renal cell carcinoma (mRCC), who subsequently receive targeted therapies (TT). Methods: We...